Impact of Anti-Inflammatory Agents on the Gene Expression Profile of Stimulated Human Neutrophils: Unraveling Endogenous Resolution Pathways
Authors:
Open Access
- 19 March 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (3) , e4902
Abstract
Adenosine, prostaglandin E2, or increased intracellular cyclic AMP concentration each elicit potent anti-inflammatory events in human neutrophils by inhibiting functions such as phagocytosis, superoxide production, adhesion and cytokine release. However, the endogenous molecular pathways mediating these actions are poorly understood. In the present study, we examined their impact on the gene expression profile of stimulated neutrophils. Purified blood neutrophils from healthy donors were stimulated with a cocktail of inflammatory agonists in the presence of at least one of the following anti-inflammatory agents: adenosine A2A receptor agonist CGS 21680, prostaglandin E2, cyclic-AMP-elevating compounds forskolin and RO 20-1724. Total RNA was analyzed using gene chips and real-time PCR. Genes encoding transcription factors, enzymes and regulatory proteins, as well as secreted cytokines/chemokines showed differential expression. We identified 15 genes for which the anti-inflammatory agents altered mRNA levels. The agents affected the expression profile in remarkably similar fashion, suggesting a central mechanism limiting cell activation. We have identified a set of genes that may be part of important resolution pathways that interfere with cell activation. Identification of these pathways will improve understanding of the capacity of tissues to terminate inflammatory responses and contribute to the development of therapeutic strategies based on endogenous resolution.Keywords
This publication has 80 references indexed in Scilit:
- Tumor Necrosis Factor-α and Mortality in Heart FailureCirculation, 2008
- T-cell Development and Function Are Modulated by Dual Specificity Phosphatase DUSP5Journal of Biological Chemistry, 2008
- SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitroBMC Cancer, 2008
- Epidermal Growth Factor Receptor and Protein Kinase C Signaling to ERK2Journal of Biological Chemistry, 2008
- SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinaseMolecular and Cellular Neuroscience, 2008
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- A2A receptors in inflammation and injury: lessons learned from transgenic animalsJournal of Leukocyte Biology, 2007
- A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasiaThe FASEB Journal, 2006
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genesCancer Genetics and Cytogenetics, 2004